Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.1016/S2213-8587(20)30342-9 http://scihub22266oqcxt.onion/10.1016/S2213-8587(20)30342-9 33128872!7598304!33128872     free     free     free Deprecated: Implicit conversion from float 213.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 213.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 213.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534       Lancet+Diabetes+Endocrinol 2020 ; 8 (12): 978-986 Nephropedia Template TP {{tp|p=33128872|t=2020. Catecholamine physiology and its implications in patients with COVID-19 |pdf=|usr=}}{{33128872}} gab.com Text Catecholamine physiology and its implications in patients with COVID-19 JO: Lancet Diabetes Endocrinol http://www.kidney.de/pget.php?&tw=1&pmid=33128872 #FOAvip The risk factors for severe COVID-19 are diverse, yet closely resemble the clinical manifestations of catecholamine excess states (eg, hypertension, cardiovascular disease, immune dysregulation, and hyperglycaemia), suggesting a potentially common basis for disease. Unfortunately, severe illness (eg, respiratory failure, compromised cardiac function, and shock) incurred by COVID-19 hinders the direct study of catecholamines in these patients, especially among those on multiple medications or those on adrenaline or noradrenaline infusions, or both. Phaeochromocytoma and paraganglioma (PPGL) are tumours that secrete catecholamines, namely adrenaline and noradrenaline, often in excess. PPGL are well studied disease processes in which the effects of catecholamines are easily discernible and therefore their potential biochemical and physiological influences in patients with COVID-19 can be explored. Because catecholamines are expected to have a role in patients with critical illness, patients on vasopressor infusions, and patients who sustain some acute and chronic physical stresses, the challenges involved in the management of catecholamine excess states are directly relevant to the treatment of patients with COVID-19. In this Personal View, we discuss the complex interplay between catecholamines and COVID-19, and the management of catecholamine excess states, while referencing relevant insights derived from the study of PPGL. Twit Text FOAVip Catecholamine physiology and its implications in patients with COVID-19 ????Lancet Diabetes Endocrinol http://www.kidney.de/pget.php?&tw=1&pmid=33128872 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=33128872 #FOAvip English Wikipedia <ref>{{Cite pmid|33128872}}</ref> Catecholamine physiology and its implications in patients with COVID-19 #MMPMID33128872 Gubbi S; Nazari MA; Taieb D; Klubo-Gwiezdzinska J; Pacak K Lancet Diabetes Endocrinol 2020[Dec]; 8 (12): 978-986 PMID33128872show ga The risk factors for severe COVID-19 are diverse, yet closely resemble the clinical manifestations of catecholamine excess states (eg, hypertension, cardiovascular disease, immune dysregulation, and hyperglycaemia), suggesting a potentially common basis for disease. Unfortunately, severe illness (eg, respiratory failure, compromised cardiac function, and shock) incurred by COVID-19 hinders the direct study of catecholamines in these patients, especially among those on multiple medications or those on adrenaline or noradrenaline infusions, or both. Phaeochromocytoma and paraganglioma (PPGL) are tumours that secrete catecholamines, namely adrenaline and noradrenaline, often in excess. PPGL are well studied disease processes in which the effects of catecholamines are easily discernible and therefore their potential biochemical and physiological influences in patients with COVID-19 can be explored. Because catecholamines are expected to have a role in patients with critical illness, patients on vasopressor infusions, and patients who sustain some acute and chronic physical stresses, the challenges involved in the management of catecholamine excess states are directly relevant to the treatment of patients with COVID-19. In this Personal View, we discuss the complex interplay between catecholamines and COVID-19, and the management of catecholamine excess states, while referencing relevant insights derived from the study of PPGL. |COVID-19/*epidemiology/metabolism/virology[MESH] |Catecholamines/*metabolism[MESH] |Humans[MESH] |Risk Factors[MESH]Catecholamine physiology and its implications in patients with COVID-1(epmc).pdf DeepDyve Pubget Overpricing